Pharmafile Logo
Pharmafocus logo
Advanced Search

Latest news from Datamonitor

February 6, 2008
Sales and Marketing Coronado Biosciences, rnai

 Coronado Biosciences’ cancer treatment effective in animal modelsCoronado Biosciences has reported that the Bcl-2 inhibitor, apogossypol, effectively killed a variety …

News

Collaborations with diagnostic firms ‘crucial to oncology progress’

February 6, 2008
Research and Development

Pharma companies should engage diagnostics companies in early phase talks if they want to fast-track innovative new cancer treatments to …

News

Takeda snaps up Amgen products

February 6, 2008
Sales and Marketing

Takeda has bought marketing rights to 13 of Amgen's early stage products, boosting its flagging pipeline and letting Amgen recoup …

News

Government and industry agree on collaboration guidelines

February 1, 2008

New guidelines to help NHS bodies work with the pharmaceutical industry have been agreed after months of negotiation, and could …

News

New consortium to run NHS clinical audit programme

February 1, 2008

The Department of Health has reorganised the way audits of patient care are carried out, handing the running of its …

News

Torisel poised to gain lymphoma licence

February 1, 2008
Sales and Marketing

Wyeth's new cancer drug Torisel is set to gain approval for use in patients with a rare and difficult to …

News

Tamiflu resistance hits Roche

February 1, 2008
Sales and Marketing

Sales of the blockbuster flu treatment Tamiflu could receive a setback from new data showing significant resistance to the drug. …

News

Latest news from Datamonitor

February 1, 2008
Research and Development

News

AstraZeneca sales strong despite Nexium’s decline

February 1, 2008
Sales and Marketing

AstraZeneca achieved sales growth of 12% in 2007, despite a worrying decline in sales from its biggest seller, anti-ulcer drug …

News

The NHS under-invests at its peril

February 1, 2008
NHS, healthcare, investment

Feature

Yondelis launched for soft tissue sarcoma

January 30, 2008
Sales and Marketing

News

Avastin’s new licence ‘more cost-effective’

January 30, 2008
Sales and Marketing

Avastin has won a broader European licence for metastatic colorectal cancer, a move manufacturer Roche believes will make it more …

News

PM Society Awards

January 28, 2008
Medical Communications advertising, awards

The Pharmaceutical Marketing Society’s Advertising Awards added their customary sparkle to the grey month of January, and celebrated the best …

News

‘Alsace Biovalley’ brand launched to promote region’s biotech innovation

January 28, 2008
Research and Development Alsace, France, biotech

France has re-branded its leading biotech cluster the ‘Alsace Biovalley’ to help the region compete for investment in Europe and …

News

Novartis’ European chief says ‘Geotailoring’ will speed decision making and bring it closer to customers

January 28, 2008
Sales and Marketing Eric Cornut, Novartis

Q: Europe’s biggest market Germany is preparing for some major reforms at the moment. How is Novartis responding to that …

News

Jimenez aims for savings and marketing rejuvenation

January 28, 2008
Sales and Marketing Jimenez, Jiminez, Novartis

The head of Novartis’ pharmaceutical business Joe Jimenez has set out his plans to make the division more efficient and …

News

Pfizer sales dip during year of restructuring

January 25, 2008
Sales and Marketing generics

Pfizer’s pharmaceutical sales fell slightly last year, hit by patent expiries and difficult market conditions for its leading drug Lipitor. …

News

Avandia hit by further restrictions

January 25, 2008
Sales and Marketing reg, safety

GlaxoSmithKline has strengthened the safety warnings on its diabetes drug Avandia following recommendations from European regulators. The drug was hit …

News

Avastin launched in UK for kidney cancer

January 25, 2008
Sales and Marketing avastin, rcc

Avastin has been launched in the UK as a first-line treatment for renal cell carcinoma (RCC) to be used in …

News

PR firm Chamberlain opens European office

January 25, 2008
Medical Communications PR

American PR firm Chamberlain is to expand into Europe with the opening of new operations in London. Chamberlain Healthcare Public …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026